BRCA1 and neoplasm: According to BRCA mutation status, BRCA1/2-mutated tumors showed a higher incidence of contralateral breast recurrence compared to non-mutated tumor (non-mutated vs. BRCA1/2-mutated tumors: 4.9% vs. 26.0%, p < 0.001).